The impact of the endothelin type A receptor on regional endothelin-1 turnover, in particular renal endothelin-1 release, in humans

被引:3
|
作者
Rullman, Eric [1 ]
Gustafsson, Thomas [1 ]
Ahlborg, Gunvor [1 ]
机构
[1] Karolinska Univ Hosp, Dept Lab Med, Karolinska Inst, Div Clin Physiol, S-14186 Huddinge, Sweden
基金
英国医学研究理事会;
关键词
pulmonary; skeletal; muscle; blood flow; mRNA; endothelin-converting enzyme 1; BIG ENDOTHELIN-1; CIRCULATING ENDOTHELIN-1; ET(B) RECEPTORS; HEALTHY HUMANS; BLOOD-PRESSURE; EXPRESSION; VASOCONSTRICTION; ATHEROSCLEROSIS; BLOCKADE; INFUSION;
D O I
10.1152/japplphysiol.00881.2009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Rullman E, Gustafsson T, Ahlborg G. The impact of the endothelin type A receptor on regional endothelin-1 turnover, in particular renal endothelin-1 release, in humans. J Appl Physiol 108:1625-1630, 2010. First published February 11, 2010; doi: 10.1152/japplphysiol. 00881.2009.-The endothelin type A (ETA) receptor was studied in six healthy subjects on two occasions with or without an ETA receptor (BQ-123) blockade. At 40 min of either BQ-123 or NaCl infusion, a concomitant infusion of the endothelin-1 (ET-1) precursor, big ET-1, was initiated to augment ET-1 formation. Blood samples were taken from catheters in a peripheral artery, the renal and femoral veins, and the pulmonary artery. Forty minutes of infusion with BQ-123 alone increased heart rate (P < 0.001) and cardiac output (CO; P < 0.01) and depressed mean arterial blood pressure (P < 0.001) and systemic vascular resistance (SVR; P < 0.01). During infusion of big ET-1 alone, CO, stroke volume, and renal blood flow decreased ( P < 0.01), whereas SVR and pulmonary and renal vascular resistance increased (P < 0.05). These responses to big ET-1 were abolished or diminished by BQ-123. Renal ET-1 release was threefold higher when big ET-1 infusion was preceded by BQ-123 infusion (P < 0.001). Arterial ET-1 concentrations rose to similar levels after big ET-1 infusion ( P < 0.01) in both trials because of elevated concomitant pulmonary uptake (P < 0.05) after ETA blockade. Although there was no net ET-1 leg exchange, leg ET-1 turnover was higher after big ET-1 was preceded by BQ-123. Gene expression of endothelin-converting enzyme 1 and ET-1 in skeletal muscle remained unaltered on both occasions. Our data demonstrate that the level of circulating ET-1 is regulated by ETA receptor-mediated negative feedback. This mechanism seems to be coupled to increased conversion of big ET-1 and is most potent in the kidneys. This emphasizes the important physiological role of ETA receptors in the kidneys, and the lung seems to be mainly a clearing organ for ET-1.
引用
收藏
页码:1625 / 1630
页数:6
相关论文
共 50 条
  • [1] Effects of endothelin-1 and endothelin-1-receptor blockade on renal function in humans
    Vuurmans, JLT
    Boer, P
    Koomans, HA
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) : 2742 - 2746
  • [2] Role of endothelin receptor subtypes in the systemic and renal responses to endothelin-1 in humans
    Kaasjager, KAH
    Shaw, S
    Koomans, HA
    Rabelink, TJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 (01): : 32 - 39
  • [3] Effect of endothelin-1 and endothelin receptor blockade on the release of microparticles
    Jung, Christian
    Lichtenauer, Michael
    Wernly, Bernhard
    Franz, Marcus
    Goebel, Bjoern
    Rafnsson, Arnar
    Figulla, Hans-Reiner
    Pernow, John
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2016, 46 (08) : 707 - 713
  • [4] Expression of endothelin-1 and endothelin-1 receptor A in canine mammary tumours
    Restucci, B.
    Martano, M.
    Maiolino, P.
    RESEARCH IN VETERINARY SCIENCE, 2015, 100 : 182 - 188
  • [5] EVIDENCE FOR RELEASE OF ENDOTHELIN-1 IN PIGS AND HUMANS
    LUNDBERG, JM
    AHLBORG, G
    HEMSEN, A
    NISELL, H
    LUNELL, NO
    PERNOW, J
    RUDEHILL, A
    WEITZBERG, E
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S350 - S353
  • [6] ADMINISTRATION OF ENDOTHELIN-1 IN HUMANS
    HAYNES, B
    WEBB, DJ
    CIRCULATION, 1991, 83 (03) : 1121 - 1121
  • [7] Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria
    Lehrke, I
    Waldherr, R
    Ritz, E
    Wagner, J
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (11): : 2321 - 2329
  • [8] HYPOXEMIA AND RELEASE OF ENDOTHELIN-1
    CARGILL, RI
    KIELY, DG
    CLARK, RA
    LIPWORTH, BJ
    THORAX, 1995, 50 (12) : 1308 - 1310
  • [9] Endothelin-1 in hepatorenal syndrome: Is endothelin-1 receptor antagonist (bosentan) effective?
    Ozdogan, O
    Goren, Z
    Tozun, N
    Moini, H
    Bilsel, S
    Celikel, C
    Kalayci, C
    Berkman, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1354 - A1354
  • [10] Comparable potent coronary constrictor effects of endothelin-1 and big endothelin-1 in humans
    Pernow, J
    Kaijser, L
    Lundberg, JM
    Ahlborg, G
    CIRCULATION, 1996, 94 (09) : 2077 - 2082